Rural Health
Resources by Topic: Pharmacy and prescription drugs
Availability of Naloxone at Rural Georgia Pharmacies, 2019
Research letter describing a study of 374 rural Georgia pharmacies. Examines pharmacists' awareness of the Georgia law allowing purchase of naloxone without a prescription, and availability and cost of the medicine.
Author(s): Jennifer L. Nguyen, Lauren R. Gilbert, Lauren Beasley, et al.
Citation: JAMA Network Open, 3(2)
Date: 02/2020
Type: Document
view details
Research letter describing a study of 374 rural Georgia pharmacies. Examines pharmacists' awareness of the Georgia law allowing purchase of naloxone without a prescription, and availability and cost of the medicine.
Author(s): Jennifer L. Nguyen, Lauren R. Gilbert, Lauren Beasley, et al.
Citation: JAMA Network Open, 3(2)
Date: 02/2020
Type: Document
view details
January 2020 MedPAC Meeting Transcript
Transcript from the Medicare Payment Advisory Commission's (MedPAC) January 2020 meeting. Covers payment adequacy and updates for hospital inpatient and outpatient services, physician and other health professional services, outpatient dialysis services and improving the ESRD payment system, skilled nursing facility services, home health agency services, long-term care hospital services, inpatient rehabilitation facility services, hospice services, and ambulatory surgical center services. Includes rural references throughout.
Date: 01/2020
Type: Document
Sponsoring organization: Medicare Payment Advisory Commission
view details
Transcript from the Medicare Payment Advisory Commission's (MedPAC) January 2020 meeting. Covers payment adequacy and updates for hospital inpatient and outpatient services, physician and other health professional services, outpatient dialysis services and improving the ESRD payment system, skilled nursing facility services, home health agency services, long-term care hospital services, inpatient rehabilitation facility services, hospice services, and ambulatory surgical center services. Includes rural references throughout.
Date: 01/2020
Type: Document
Sponsoring organization: Medicare Payment Advisory Commission
view details
340B Drug Discount Program: Oversight of the Intersection with the Medicaid Drug Rebate Program Needs Improvement
Examines state and federal efforts to prevent duplicate discounts under the 340B and Medicaid Drug Rebate Programs and identifies limitations and weaknesses in federal oversight. Provides recommendations to the Centers for Medicare and Medicaid Services and the Health Resources and Services Administration to strengthen oversight of these programs.
Additional links: Full Report
Date: 01/2020
Type: Document
Sponsoring organization: Government Accountability Office
view details
Examines state and federal efforts to prevent duplicate discounts under the 340B and Medicaid Drug Rebate Programs and identifies limitations and weaknesses in federal oversight. Provides recommendations to the Centers for Medicare and Medicaid Services and the Health Resources and Services Administration to strengthen oversight of these programs.
Additional links: Full Report
Date: 01/2020
Type: Document
Sponsoring organization: Government Accountability Office
view details
Trends in Opioids Prescribed at Discharge From Emergency Departments Among Adults: United States, 2006–2017
Examines trends in emergency department (ED) discharge opioid prescribing for adults from 2006–2007 through 2016–2017. Provides data by selected patient and hospital characteristics and the type of opioids prescribed. Table 1 includes data on the percent of ED patients prescribed an opioid at discharge by location of patient residence for metropolitan and nonmetropolitan areas.
Author(s): Pinyao Rui, Loredana Santo, Jill J. Ashman
Date: 01/2020
Type: Document
Sponsoring organization: National Center for Health Statistics
view details
Examines trends in emergency department (ED) discharge opioid prescribing for adults from 2006–2007 through 2016–2017. Provides data by selected patient and hospital characteristics and the type of opioids prescribed. Table 1 includes data on the percent of ED patients prescribed an opioid at discharge by location of patient residence for metropolitan and nonmetropolitan areas.
Author(s): Pinyao Rui, Loredana Santo, Jill J. Ashman
Date: 01/2020
Type: Document
Sponsoring organization: National Center for Health Statistics
view details
Acceptability of Buprenorphine as A Treatment for Opioid Use Disorders: Experiences of Health Providers In Indiana Rural Counties
Slides from a presentation at the 2020 American Public Health Association conference focused on utilizing buprenorphine for Medication Assisted Treatment (MAT). Examines 29 semi-structured interviews of medical and non-medical professionals from rural counties in Indiana about barriers and facilitators of buprenorphine use.
Author(s): Josephine Mwangi
Date: 2020
Type: Presentation Slides
Sponsoring organization: Indiana University Bloomington
view details
Slides from a presentation at the 2020 American Public Health Association conference focused on utilizing buprenorphine for Medication Assisted Treatment (MAT). Examines 29 semi-structured interviews of medical and non-medical professionals from rural counties in Indiana about barriers and facilitators of buprenorphine use.
Author(s): Josephine Mwangi
Date: 2020
Type: Presentation Slides
Sponsoring organization: Indiana University Bloomington
view details
Buyback Program of Unused Prescription Opioids in US Rural Communities, 2017–2018
Describes a buyback intervention that was designed to encourage rural, ambulatory surgery patients to return unused prescription opioids to a U.S. Department of Veterans Affairs (VA) hospital. Provides data on patient characteristics as well as percent of opioids prescribed and returned during 2017 and 2018. Includes implications for public health.
Author(s): Jean Liu, Julie Franklin, Frank Gesek, Joseph Anderson
Citation: American Journal of Public Health, 110(9), 1318-1324
Date: 2020
Type: Document
view details
Describes a buyback intervention that was designed to encourage rural, ambulatory surgery patients to return unused prescription opioids to a U.S. Department of Veterans Affairs (VA) hospital. Provides data on patient characteristics as well as percent of opioids prescribed and returned during 2017 and 2018. Includes implications for public health.
Author(s): Jean Liu, Julie Franklin, Frank Gesek, Joseph Anderson
Citation: American Journal of Public Health, 110(9), 1318-1324
Date: 2020
Type: Document
view details
The Rural Health Care Coordination Network Partnership Program: Avera St. Mary's Completing the Circle Project
Describes and examines the impact of a care coordination program developed by Avera St. Mary's located in Pierre, South Dakota. Used a Patient Centered Medical Home (PCMH) model, providing services to patients with type 2 diabetes, one-third of whom were American Indian. The program's care team connected patients to resources and coordinated the patient's primary care providers, medications, specialists, other health care services, and a variety of social services. Funded under the Rural Health Care Coordination Network Partnership Grant Program from 2015-2018.
Date: 2020
Type: Document
Sponsoring organizations: NORC Walsh Center for Rural Health Analysis, University of Minnesota Rural Health Research Center
view details
Describes and examines the impact of a care coordination program developed by Avera St. Mary's located in Pierre, South Dakota. Used a Patient Centered Medical Home (PCMH) model, providing services to patients with type 2 diabetes, one-third of whom were American Indian. The program's care team connected patients to resources and coordinated the patient's primary care providers, medications, specialists, other health care services, and a variety of social services. Funded under the Rural Health Care Coordination Network Partnership Grant Program from 2015-2018.
Date: 2020
Type: Document
Sponsoring organizations: NORC Walsh Center for Rural Health Analysis, University of Minnesota Rural Health Research Center
view details
Opioid Prescribing Among Adults With Disabilities in the United States After the 2014 Federal Hydrocodone Rescheduling Regulation
Examines the impact of the 2014 federal rescheduling regulation regarding hydrocodone-combination products on Medicare beneficiaries with disabilities. Provides maps of prolonged opioid use by Medicare beneficiaries with disabilities by state before and after the regulation was implemented. Includes data analysis of beneficiaries in metropolitan, urban, and rural areas.
Author(s): Victor Law, Yong-Fang Kuo, Mukaila A. Raji, Jacques Baillargeon
Citation: Public Health Reports, 135(1), 114-123
Date: 12/2019
Type: Document
view details
Examines the impact of the 2014 federal rescheduling regulation regarding hydrocodone-combination products on Medicare beneficiaries with disabilities. Provides maps of prolonged opioid use by Medicare beneficiaries with disabilities by state before and after the regulation was implemented. Includes data analysis of beneficiaries in metropolitan, urban, and rural areas.
Author(s): Victor Law, Yong-Fang Kuo, Mukaila A. Raji, Jacques Baillargeon
Citation: Public Health Reports, 135(1), 114-123
Date: 12/2019
Type: Document
view details
340B Drug Discount Program: Increased Oversight Needed to Ensure Nongovernmental Hospitals Meet Eligibility Requirements
Provides an overview of the Government Accountability Office's (GAO) review of 258 nongovernmental hospitals that participate in the 340B Drug Pricing Program and their contracts with state and local governments. Evaluates the contracts to determine if they meet the eligibility requirement to serve low-income individuals. Outlines weaknesses in the Health Resources and Services Administration's review of the hospital contracts and offers six recommendations to improve the contract review process.
Additional links: Full Report
Date: 12/2019
Type: Document
Sponsoring organization: Government Accountability Office
view details
Provides an overview of the Government Accountability Office's (GAO) review of 258 nongovernmental hospitals that participate in the 340B Drug Pricing Program and their contracts with state and local governments. Evaluates the contracts to determine if they meet the eligibility requirement to serve low-income individuals. Outlines weaknesses in the Health Resources and Services Administration's review of the hospital contracts and offers six recommendations to improve the contract review process.
Additional links: Full Report
Date: 12/2019
Type: Document
Sponsoring organization: Government Accountability Office
view details
Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder
Results of a cross-sectional county-level study using all reported direct-to-physician pharmaceutical payments from manufacturers of opioid use disorder medications from 2014-2017, as well as demographic and economic data from 3,140 counties. Features statistics with breakdowns by metropolitan, micropolitan, and rural areas.
Author(s): Thuy Nguyen, Barbara Andraka-Christou, Kosali Simon, W. David Bradford
Citation: JAMA Network Open, 2(12)
Date: 12/2019
Type: Document
view details
Results of a cross-sectional county-level study using all reported direct-to-physician pharmaceutical payments from manufacturers of opioid use disorder medications from 2014-2017, as well as demographic and economic data from 3,140 counties. Features statistics with breakdowns by metropolitan, micropolitan, and rural areas.
Author(s): Thuy Nguyen, Barbara Andraka-Christou, Kosali Simon, W. David Bradford
Citation: JAMA Network Open, 2(12)
Date: 12/2019
Type: Document
view details